Medical Devices & Diagnostics · LP-214
Pregnancy rapid test Diagnostic test
Device / diagnostic dossier. Catalogue identity is separated from unresolved product-specific fields and from external scientific references.
Development record
This dossier integrates an archived editorial source review dated 2026-09-11. Website reconciliation does not constitute a new medical or regulatory review. Controlled product approval, use instructions and supply status remain unestablished.
- Portfolio reference
- LP-214Medical Devices & Diagnostics
- Product type
- Pregnancy rapid testDiagnostic test
- Registration
- Not establishedProduct-specific evidence required
- Availability
- Not marketedNo offer of supply
01 · Layers 01–02 · Evidence boundary
What this public record establishes — and what remains held.
- Portfolio reference
- LP-214
- Product type
- Pregnancy rapid test
- Presentation
- Diagnostic test
- Configuration / specification
- Strip; Cassette; Midstream
- Catalogue pack
- Single-use pouch; carton 25/50
- Public status
- Development presentation
Layer 01 · Controlled catalogue facts
- Product type: pregnancy rapid test.
- Portfolio form/type: diagnostic test.
- Proposed formats: strip, cassette and midstream.
- General proposed pack: single-use pouch; carton 25/50.
Layer 02 · Unresolved product-specific fields
- Manufacturer/model identifiers for each format.
- Specimen type and exact intended use/users (professional vs self-test).
- hCG detection threshold, read window, controls, sensitivity/specificity and interference data.
- Format-to-pack mapping, storage, shelf life, registration and supply status.
02 · Configurations
Keep device configuration separate from model and performance claims.
| Configuration | Catalogue value | Product type | Presentation detail | Packaging relationship | Evidence status |
|---|---|---|---|---|---|
| A | Strip | Pregnancy rapid test | — | Single-use pouch; carton 25/50 not mapped | Model, intended users and performance are not supplied. |
| B | Cassette | Pregnancy rapid test | — | Single-use pouch; carton 25/50 not mapped | Model, intended users and performance are not supplied. |
| C | Midstream | Pregnancy rapid test | — | Single-use pouch; carton 25/50 not mapped | Model, intended users and performance are not supplied. |
The table reproduces or structures catalogue-level fields. It does not create an approved SKU, instruction or specification where the source record does not provide one.
03 · External reference context
Device and diagnostic background
A pregnancy rapid test is an in vitro diagnostic device designed to detect human chorionic gonadotropin in an authorized specimen, commonly urine. Strip, cassette and midstream formats have different collection and handling instructions. They are not medicines and do not by themselves establish pregnancy location, viability or gestational age. Test sensitivity and intended use belong to the particular validated assay.
Intended-use context
The result depends partly on timing relative to conception and the amount of hormone in the sample. Testing too early can produce a negative result despite pregnancy. A positive result should be considered in the wider clinical context, and pain or bleeding may require urgent assessment. This catalogue does not establish a detection threshold, earliest testing day, reading time or model-level accuracy claim for any of the listed formats.
Interpretation and safety boundaries
False results can occur with incorrect timing, sample handling, degraded reagents or factors affecting hCG. Reading a device outside its specified window can be misleading. A negative result does not exclude a very early pregnancy, and a positive result cannot exclude ectopic pregnancy. Severe abdominal pain, fainting or substantial bleeding needs prompt medical care regardless of the test. Reagents and small components must be handled safely.
Selected external context only. It is not a complete risk profile or Luang Pharma approved labelling. The exact authorised IFU/label and applicable professional guidance control product use.
System, model and handling evidence
The three formats need separate authorized instructions and performance specifications. Confirm specimen type, detection threshold, controls, read window and intended professional or self-test setting. Do not assume that the same manufacturer or performance evidence applies to all formats.
Keep each test in its sealed pouch until use and follow the specified sample, temperature and read-window instructions. Check expiry and control validity. Do not reuse a device or interpret an invalid result as negative; use the follow-up process described in the authorized instructions.
Final instructions, storage conditions, shelf life and any after-opening/in-use limits require the exact controlled product documentation; none is created from a comparator reference.
Points for professional review
Confirm model identity, local registration, intended users and validated performance. Ensure clear instructions and appropriate guidance on unexpected results and symptoms needing clinical assessment.
04 · Layer 04 · Documentation gate
Model, IFU and performance evidence control the device answer.
Before a device/diagnostic record can support procurement, use or compatibility claims, the exact model and intended-use evidence must be identified.
Model-specific IFU and intended-use statement.
Analytical/clinical performance and interference evidence.
Self-test/professional-use authorisation as applicable.
Format/SKU and packaging matrix.
Device registration/conformity evidence for the destination.
Editorial source check: archived record dated 2026-09-11.
Qualified product/medical review: Not recorded at B06 checkpoint
Approved Luang Pharma IFU/label: Not provided or established
Registration / availability / supply: not established by this public record.
05 · Layer 03 · Sources & review
External references are attributed, not adopted as Luang Pharma labelling.
| Source | Recorded revision / check | How it is used |
|---|---|---|
| FDA: home pregnancy testsArchived source classification: government or public health guidance | Archived access check: 2026-09-11 | External reference; not Luang Pharma labelling or evidence of equivalence. |
External sources may describe authorised products, public-health guidance or device classes. They do not establish equivalence, approval, model performance, manufacturing status or supply eligibility for LP-214.
Professional enquiries
Request product-specific evidence for LP-214.
State the exact presentation or configuration, organisation, destination and evidence you need. The public portfolio record is not an offer of supply.